USAQ
Price
$0.17
Change
-$0.05 (-22.73%)
Updated
Aug 8 closing price
Capitalization
2.13M
XVIPF
Price
$20.54
Change
-$2.46 (-10.70%)
Updated
Aug 4 closing price
Capitalization
621.89M
Interact to see
Advertisement

USAQ vs XVIPF

Header iconUSAQ vs XVIPF Comparison
Open Charts USAQ vs XVIPFBanner chart's image
QHSLab
Price$0.17
Change-$0.05 (-22.73%)
Volume$8.91K
Capitalization2.13M
Xvivo Perfusion AB
Price$20.54
Change-$2.46 (-10.70%)
Volume$1.05K
Capitalization621.89M
USAQ vs XVIPF Comparison Chart in %
Loading...
USAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XVIPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
USAQ vs. XVIPF commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is USAQ is a Hold and XVIPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (USAQ: $0.19 vs. XVIPF: $20.54)
Brand notoriety: USAQ and XVIPF are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: USAQ: 132% vs. XVIPF: 249%
Market capitalization -- USAQ: $2.13M vs. XVIPF: $621.89M
USAQ [@Medical/Nursing Services] is valued at $2.13M. XVIPF’s [@Medical/Nursing Services] market capitalization is $621.89M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $233.71B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.52B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

USAQ’s FA Score shows that 0 FA rating(s) are green whileXVIPF’s FA Score has 0 green FA rating(s).

  • USAQ’s FA Score: 0 green, 5 red.
  • XVIPF’s FA Score: 0 green, 5 red.
According to our system of comparison, USAQ is a better buy in the long-term than XVIPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

USAQ’s TA Score shows that 5 TA indicator(s) are bullish while XVIPF’s TA Score has 5 bullish TA indicator(s).

  • USAQ’s TA Score: 5 bullish, 4 bearish.
  • XVIPF’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, XVIPF is a better buy in the short-term than USAQ.

Price Growth

USAQ (@Medical/Nursing Services) experienced а -13.30% price change this week, while XVIPF (@Medical/Nursing Services) price change was -10.71% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.03%. For the same industry, the average monthly price growth was +0.41%, and the average quarterly price growth was +3.73%.

Industries' Descriptions

@Medical/Nursing Services (-2.03% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XVIPF($622M) has a higher market cap than USAQ($2.13M). USAQ YTD gains are higher at: -23.790 vs. XVIPF (-50.034). XVIPF has higher annual earnings (EBITDA): 182M vs. USAQ (327K). XVIPF has more cash in the bank: 323M vs. USAQ (61.1K). USAQ has less debt than XVIPF: USAQ (1.6M) vs XVIPF (111M). XVIPF has higher revenues than USAQ: XVIPF (823M) vs USAQ (2.29M).
USAQXVIPFUSAQ / XVIPF
Capitalization2.13M622M0%
EBITDA327K182M0%
Gain YTD-23.790-50.03448%
P/E RatioN/A56.22-
Revenue2.29M823M0%
Total Cash61.1K323M0%
Total Debt1.6M111M1%
FUNDAMENTALS RATINGS
USAQ vs XVIPF: Fundamental Ratings
USAQ
XVIPF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
90
Overvalued
PROFIT vs RISK RATING
1..100
10090
SMR RATING
1..100
10083
PRICE GROWTH RATING
1..100
5995
P/E GROWTH RATING
1..100
10096
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

USAQ's Valuation (44) in the null industry is somewhat better than the same rating for XVIPF (90). This means that USAQ’s stock grew somewhat faster than XVIPF’s over the last 12 months.

XVIPF's Profit vs Risk Rating (90) in the null industry is in the same range as USAQ (100). This means that XVIPF’s stock grew similarly to USAQ’s over the last 12 months.

XVIPF's SMR Rating (83) in the null industry is in the same range as USAQ (100). This means that XVIPF’s stock grew similarly to USAQ’s over the last 12 months.

USAQ's Price Growth Rating (59) in the null industry is somewhat better than the same rating for XVIPF (95). This means that USAQ’s stock grew somewhat faster than XVIPF’s over the last 12 months.

XVIPF's P/E Growth Rating (96) in the null industry is in the same range as USAQ (100). This means that XVIPF’s stock grew similarly to USAQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
USAQXVIPF
RSI
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
48%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
47%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
50%
MACD
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
42%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
48%
Advances
ODDS (%)
Bullish Trend 13 days ago
63%
Bullish Trend 28 days ago
20%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
55%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
USAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XVIPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSJFX64.570.45
+0.70%
Invesco Main Street R5
DDVCX14.120.07
+0.50%
Macquarie Value C
LGCCX18.990.08
+0.42%
Lord Abbett Global Equity C
FESMX11.860.02
+0.17%
First Eagle U.S. SMID Cap Opportunity I
IVFLX4.32-0.01
-0.23%
Federated Hermes Intl Strat Val Div R6

USAQ and

Correlation & Price change

A.I.dvisor tells us that USAQ and BIOQ have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that USAQ and BIOQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To USAQ
1D Price
Change %
USAQ100%
-13.30%
BIOQ - USAQ
27%
Poorly correlated
N/A
ADMT - USAQ
21%
Poorly correlated
N/A
TLTFF - USAQ
9%
Poorly correlated
+3.57%
WUXIF - USAQ
7%
Poorly correlated
N/A
XVIPF - USAQ
4%
Poorly correlated
N/A
More

XVIPF and

Correlation & Price change

A.I.dvisor tells us that XVIPF and INMD have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XVIPF and INMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XVIPF
1D Price
Change %
XVIPF100%
N/A
INMD - XVIPF
20%
Poorly correlated
-1.81%
LUNG - XVIPF
8%
Poorly correlated
-4.32%
VPTDF - XVIPF
7%
Poorly correlated
-4.57%
OM - XVIPF
6%
Poorly correlated
-9.73%
USAQ - XVIPF
4%
Poorly correlated
-13.30%
More